Working… Menu

Assessing Usefulness of Virtual Reality Mobile Application in Flexible Videoscope Airway Training (AURA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03663296
Recruitment Status : Recruiting
First Posted : September 10, 2018
Last Update Posted : September 10, 2018
Information provided by (Responsible Party):
National University Hospital, Singapore

Brief Summary:

Flexible videoscope orotracheal intubation (FOI) technique is considered an important option in the management of predicted difficult airways. However, it is rarely performed in daily practice. Yet emergency physicians are expected to be able to perform this skill expertly during a crisis scenario. If it is not completed in a timely and proper fashion, the patient will deteriorate rapidly, resulting in morbidity or fatality.

There is a significant learning curve to master this complex psychomotor skill. Providing sufficient training in FOI, particularly hands-on experience in real patients is difficult. Patients with known difficult airway requiring FOI present infrequently to the emergency room. Using patients with normal airway purely for teaching of FOI is ethically controversial. To avoid technical and ethical concerns of training involving real patients, conventional teaching methods incorporate the use of a low-fidelity manikin in replacement. However, the manikin anatomy often lacks the realism of a live human.

The addition of virtual reality technology, in the form of a low-cost mobile application (Airway Ex) into the conventional simulation, may optimize learning by providing an ethical, cost-effective and more realistic modality to acquire the basic skills of FOI. If it is proven to be effective, efforts to integrate virtual reality technology into routine training of such procedures in the ED should be promoted.

We hypothesize that the addition of virtual reality mobile application to conventional training will improve procedural skill dexterity and proficiency and hence, improve learner's satisfaction and confidence in performing FOI.

Condition or disease Intervention/treatment Phase
Education, Medical Other: Airway Ex App Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Other
Official Title: Assessing Usefulness of Virtual Reality Mobile Application in Flexible Videoscope Airway Training - a Randomised Controlled Trial
Actual Study Start Date : September 1, 2018
Estimated Primary Completion Date : December 1, 2018
Estimated Study Completion Date : December 1, 2018

Arm Intervention/treatment
Experimental: Interventional
Additional 30 minutes of self-directed learning and practice using the mobile application, after conventional training session
Other: Airway Ex App
30 minutes of self-directed learning and practice using the mobile application

No Intervention: Control
Conventional training session which includes didactic teaching and low-fidelity simulation session involving trainer's demonstration, followed by hands-on practice

Primary Outcome Measures :
  1. Time taken for successful intubation [ Time Frame: 5 minutes ]
    time from advancing scope from manikin's mouth to confirmed placement of endotracheal tube through visualisation with videoscope

Secondary Outcome Measures :
  1. Time taken for visualisation of vocal cords [ Time Frame: 1 minute ]
    time from advancing scope from manikin's mouth to first visualisation of vocal cords with videoscope

Other Outcome Measures:
  1. Quality of flexible videoscope manipulation ability [ Time Frame: 5 minutes ]
    By blinded assessor using validated Five-point Global Rating Scale of Fiberoptic Bronchoscope Manipulation Ability. Score of 1 indicates very poor techniques whereas a score of 5 indicates clearly superior techniques.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All doctors from Accidental & Emergency Department of National University Hospital, Singapore

Exclusion Criteria:

  • Refusal for consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03663296

Layout table for location contacts
Contact: Ying Wei Yau +65-6779 5555

Layout table for location information
National University Hospital, Singapore Recruiting
Singapore, Singapore, 119074
Contact: Ying Wei Yau    +65-6779 5555   
Sponsors and Collaborators
National University Hospital, Singapore
Layout table for investigator information
Principal Investigator: Ying Wei Yau National University Hospital, Singapore

Layout table for additonal information
Responsible Party: National University Hospital, Singapore Identifier: NCT03663296     History of Changes
Other Study ID Numbers: AURA
First Posted: September 10, 2018    Key Record Dates
Last Update Posted: September 10, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No